Does Lifelong Low LDL-Cholesterol (Genetic) Reduce Heart Risk? YES!

Importance  There are genetic variants that are inherited at birth and are associated with significantly lower low-density lipoprotein cholesterol (LDL-C) concentrations for life. These genetic "experiments" permit asking the question whether a lifelong lower LDL-C lowers the risks of coronary heart disease (CHD) like heart attacks. I published data like this in 2012 and showed with my co-authors that there was a large reduction in the risk of CHD in those born with genetic variants leading to a lifelong low LDL-C. A new study using a large, multiracial prospective population adds to this data.

STUDY: This studied included participants from 5 National Heart, Lung, and Blood Institute (NHLBI) studies and the UK Biobank. NHLBI study participants aged 5 to 84 years were recruited between 1971 and 2002 across the US and underwent whole-genome sequencing. UK Biobank participants aged 40 to 69 years were recruited between 2006 and 2010 in the UK and underwent whole-exome sequencing. Data were analyzed from June 2021 to October 2022.

RESULTS  Among 19 073 NHLBI participants in the USA, only 139 (0.7%) carried the genetic variation that was associated with 49 mg/dL lower LDL-C. Over a follow-up of 21.5 years, incident CHD was observed in 8.6% vs  16.0% of the "non-inherited" group, or a 50% favorable reduction in CHD.

Among 190 464 UK Biobank participants, 0.4% carried a favorable genetic pattern associated with 45 mg/dL lower LDL-C. Estimated CHD risk by age 75 years was 3.7% vs 7.0% in noncarriers, corresponding to a 50 % reduction in CHD.

CONCLUSIONS

Among 209 537 individuals in this study, 0.4% carried a favorable genetic variaton that was associated with less exposure to LDL-C over there whole life. There was a 49% lower risk of CHD. This supports the Cholesterol Hypothesis that lowering LDL-C throughout life using lifestyle, and if needed, supplements and medication, favor the avoidance of heart disease and heart events like heart attacks. 

Author
Dr. Joel Kahn

You Might Also Enjoy...

Why You Want to Add GG to Your Statin Prescription

GG supplementation boosts the synthesis of essential cell signaling molecules not achieved by CoQ10 supplementation. GG supplementation mitigates many of the side effects of statins, which affect mitochondrial function and cellular health.

Heart Disease in Women: A Little Bit Goes Far for Harm

In women, major adverse cardiovascular events appeared to emerge at a lower PB, and to rise more sharply. Findings support sex-specific interpretation of coronary computed tomography angiography-derived plaque metrics for timely intervention in women.

Ezetimibe (Zetia) May Lower the Risk of Dementia Sevenfold!

The animal and cultured-cell models for which we present data substantiate that ezetimibe indeed reduces aggregates across a broad spectrum of biological systems, and that it does so by blocking or dissociating dysfunctional (or non-functional) interaction